OptimizeRx Corporation
OPRX
$5.12
$0.224.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -109.86% | 544.42% | -49.15% | 169.67% | -2,719.23% |
| Total Depreciation and Amortization | -19.52% | 32.07% | 0.00% | -8.50% | -17.56% |
| Total Amortization of Deferred Charges | 341.98% | -68.11% | -50.20% | 193.10% | 216.36% |
| Total Other Non-Cash Items | -21.48% | 19.02% | 31.45% | -4.49% | -48.31% |
| Change in Net Operating Assets | -93.75% | -111.04% | -2,726.67% | -99.07% | 178.57% |
| Cash from Operations | -106.59% | 121.36% | -29.80% | 18.04% | 1,851.52% |
| Capital Expenditure | -90.91% | -10.00% | 0.00% | 62.96% | -58.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 40.35% | 44.66% |
| Cash from Investing | -110.19% | 2,160.00% | 77.27% | 47.62% | 30.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.64% | -400.00% | 88.89% | -800.00% | 80.00% |
| Issuance of Common Stock | -- | -95.86% | -- | -- | -- |
| Repurchase of Common Stock | 98.23% | -902.08% | -1,820.00% | 94.25% | 73.15% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21.46% | -1,236.43% | 94.27% | -667.46% | 79.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -183.10% | 31.08% | 24,350.00% | -99.62% | 216.28% |